Abel 1983.
| Methods | Quasi‐randomized, open‐label trial; beta‐blocker versus standard care | |
| Participants | Overall: 91 participants; beta‐blocker: 41 participants; standard care: 50 participants (100% of participants were taking beta‐blockers preoperatively) Mean age: 56.6 years Percentage of female participants: 17 |
|
| Interventions | Participants received either propranolol or standard care; treatment was initiated during surgery and was continued until hospital discharge | |
| Outcomes | Primary outcomes: supraventricular arrhythmias; secondary outcomes: ventricular arrhythmias, myocardial infarction, hospital mortality | |
| Notes | Type of surgery: elective coronary artery bypass grafting (CABG) | |
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | High risk | Quasi‐randomization (last digit of hospital record number) |
| Allocation concealment (selection bias) | High risk | See above |
| Blinding of participants (performance bias) All outcomes | High risk | Open‐label trial |
| Blinding of doctors/personnel (performance bias) All outcomes | High risk | Open‐label trial |
| Blinding of outcome assessors (detection bias) All outcomes | High risk | Open‐label trial |
| Incomplete outcome data (attrition bias) All outcomes | High risk | 9 withdrawals in beta‐blocker group due to bradycardia (2), severe hypotension (3), preoperative myocardial infarction (2), biventricular failure (1), and cardiac arrest (1) |
| Intention to treat analysis | High risk | Participants were not analysed as randomly assigned |
| Selective reporting (reporting bias) | Low risk | Not detected |
| Other bias | Low risk | Not detected |